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doi:10.1016/j.ejvs.2010.02.004Abstract Objective: Vascular surgical specialisation is associated with improved outcomes.
We aimed to assess the effect of anaesthetic specialisation on outcome following major
vascular surgery.
Design: Retrospective cohort study.
Methods: Patients undergoing major vascular surgery (lower limb revascularisation, elective
and ruptured abdominal aortic aneurysm repair, endovascular aneurysm repair and carotid
endarterectomy) over a five-year period were identified from a prospective database. The
primary outcomes were death within 30 days and death within two years of surgery. Potential
risk factors for mortality were assessed using multivariate logistic regression modelling.
Results: The analysis cohort comprised 1155 patients followed up for a median of 583 days.
Mortality within two years of surgery was 16%. For the overall cohort, care from vascular
anaesthetists was independently associated with reduced 30-day (odds ratio 0.22; 95% CI
0.12e0.62) and medium-term mortality (0.31; 95% CI 0.18e0.55). For elective patients
(nZ 851), vascular anaesthesia reduced two-year mortality (odds ratio 0.29; 95% CI
0.15e0.58; PZ 0.0004) though not 30-day mortality (odds ratio 0.55; 95% CI 0.15e1.95;
PZ 0.35). For emergency patients, care by a vascular anaesthetist influenced neither
30-day mortality (odds ratio 0.33; 95% CI 0.08e1.41; PZ 0.13) nor medium-term mortality
(odds ratio 0.45; 95% CI 0.17e1.21; PZ 0.11).
Conclusions: Anaesthetic specialisation reduced early- and medium-term mortality rates
following major vascular surgery. If replicated by prospective studies, these results suggest
that vascular surgery services would benefit from specialised anaesthetic support.
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720 S.R. Walsh et al.Introduction trauma were excluded. Patients undergoing venous surgerySurgical specialisation and high-volume practice both
improve outcome following major complex surgery.1,2
Similar patterns exist in a range of vascular procedures,
including carotid endarterectomy,3 abdominal aortic
aneurysm (AAA) repair 4 and lower limb revascularisation.5
Peri-operative mortality from major vascular surgery has
decreased slightly in recent years, partly through increased
use of endovascular techniques.6 Nevertheless, immediate
and medium-term mortality remain considerable.7,8
In contrast to surgery, anaesthesia has largely remained
a broad-based, general speciality. Contemporary data from
the United Kingdom reveal that one-fifth of elective and
over half of ruptured AAA patients are cared for by
anaesthetists who undertake less than five AAA repairs per
annum.9 Emerging surgical oncology data suggest that peri-
operative anaesthetic techniques may have an effect on
eventual oncological outcome.10 Little is known about the
relationship between anaesthetic subspecialisation and
outcome following major vascular surgery. We hypothesised
that care provided by specialist vascular anaesthetists
would improve peri-operative and medium-term outcome
following major vascular surgery.
Methods
The Norfolk and Norwich Vascular Unit is a tertiary referral
vascular unit serving a population of approximately eight
hundred thousand people. The unit undertakes a full range
of emergency and elective vascular surgery. All elective
and emergency vascular surgeries are provided by five
consultant vascular surgeons. There are six consultant
anaesthetists with a special interest in vascular surgery.
These anaesthetists undertake at least three elective
vascular surgery lists each month and are members of the
United Kingdom Vascular Anaesthesia Society. There is no
separate vascular anaesthesia on-call rota. Emergency
vascular patients are cared for by the anaesthetist of the
day, who may or may not have a vascular interest.
All patients undergoing surgery in the unit are entered
into a prospective database, based upon the Vascular
Society of Great Britain and Ireland’s National Vascular
Database. Age, pre-operative blood results, co-morbidities
(diabetes, smoking, hypertension, ischaemic heart disease,
renal failure), electrocardiogram findings, operating
surgeon, attending anaesthetist, type of surgery, blood
loss, duration of surgery, elective versus emergency
procedure, intra-operative haemodynamic variables, post-
operative complications and death within 30 days of surgery
are recorded for each patient.
Patients who underwent surgery between 2003 and 2007
were extracted from this database. The patient list was
then cross-referenced with the monthly departmental audit
records and surgeon operating logs to ensure complete data
capture. Only patients undergoing an indexed procedure
(elective open AAA repair, rupture AAA repair, endovascular
AAA repair, carotid endarterectomy, lower limb revascu-
larisation) were included in the analyses. Those patients
undergoing other procedures e.g. haemodialysis access
formation, major or minor limb amputation or vascularare not entered into the database.
Logistic regression models were constructed to identify
factors correlating with 30-day mortality and medium-term
survival. Medium-term survival was defined as survival up to
two years post-operatively. Patients were censored when
they died, were lost to follow-up or exceeded two years
follow-up. Medium-term survival was determined by cross-
referencing the patient cohort with the hospital adminis-
trative database. For patients who underwent multiple
procedures, only the first procedure was included in the
analyses. Univariate logistic regression models were used to
test the effect of each potential prognostic variable on
outcome. Each model initially considered the following
variables: haemoglobin level, white cell count, serum
sodium, serum potassium, serum urea, serum creatinine,
age, male gender, mode of admission (elective or emer-
gency), diabetes, ischaemic heart disease or congestive
cardiac failure, hypertension, smoking status, abnormal
pre-operative electrocardiogram, lowest intra-operative
systolic blood pressure, highest intra-operative heart
rate, operative time, intra-operative blood loss (<1 L,
1e2 L, 2e5 L or >5 L). The type of surgery was also
included in each model (lower limb revascularisation,
elective open abdominal aortic aneurysm, elective endo-
vascular aneurysm repair, carotid endarterectomy, open
repair of ruptured abdominal aortic aneurysm). Lower limb
revascularisation was used as the reference group to which
the other procedure types were compared.
Significant univariate correlates (defined as P 0.1)
were then entered into forward stepwise logistic regression
models to test for independence. A p-value of 0.05 or less
was considered significant in the multivariate models.
Models were constructed for the overall patient cohort.
Further models were constructed using datasets restricted
to elective patients only, emergency patients only and with
ruptured AAA patients excluded. Factors influencing
survival were assessed by KaplaneMeier and Cox regression
as required. All p-values are two-sided. Continuous vari-
ables are reported as mean (standard deviation) and cate-
gorical variables as absolute number (%), unless stated
otherwise. The statistical analyses were performed using
Statsdirect 2.7.3 (Statsdirect Ltd, Altrincham, UK).
Results
The initial search yielded 2295 patients. Of these 1155 had
undergone an indexed procedure. The majority of the
cohort were male, three-quarters underwent elective
procedures and about one-quarter were cared for by
a vascular anaesthetist (Table 1). Candidate variables
which did not reach significance in the univariate analyses
have been omitted from the results tables.
Peri-operative mortality
Factors affecting 30-day mortality were initially modelled
using the entire cohort of 1155 patients. Univariate logistic
regression modelling identified a number of factors that
influenced peri-operative mortality in this cohort (Table 2).
In the multivariate model, care by a vascular anaesthetist
Table 1 Characteristics of patients eligible for inclusion.
Characteristic Overall cohort (nZ 1155) Elective only (nZ 851) Emergency only (nZ 304)
Mean age SD 72 8.5 years 71 8.5 years 74 8.4 years
Male gender 858 (74%) 618 (73%) 240 (79%)
Type of procedure
Elective AAA repair 306 (26%) 305 (36%) e
Rupture AAA repair 206 (18%) e 206 (68%)
EVAR 56 (5%) 56 (7%) 1 (0.3%)
Carotid endarterectomy 347 (30%) 317 (37%) 39 (12.7%)
Lower limb revascularisation 240 (21%) 174 (20%) 58 (19%)
Peri-operative deaths 63 (6%) 15 (2%) 48 (16%)
Deaths within 2 years 179 (16%) 95 (11%) 84 (28%)
Vascular anaesthetist present 297 (26%) 265 (31%) 32 (11%)
SD: standard deviation AAA: abdominal aortic aneurysm EVAR: endovascular aneurysm repair.
Anaesthetic Specialisation and Outcome 721reduced mortality (odds ratio 0.33; 95% CI 0.12e0.62;
PZ 0.002). Pre-operative serum creatinine had a small
adverse influence on survival (odds ratio 1.00; 95% CI 1.00e
1.01). Surgery for a ruptured AAA, peri-operative blood loss
and increasing age were all associated with an increased
risk of peri-operative death. Given the strong influence of
ruptured AAA and intra-operative blood loss on 30-day
mortality, the analysis was repeated with all emergency
patients excluded. The elective only model encompassed
851 patients, of whom 15 died peri-operatively (2%). In thisTable 2 Factors affecting 30-day survival in the entire cohort (
Variable Alive at 30 days
(nZ 1092)
Death within
30 days (nZ 63)
Univ
rati
Vascular anaesthetist 292 (27%) 5 (8%) 0.2
Creatinine (mmol/L) 108 (44.4) 146 (64.7) 1.0
Age (years) 72 (8.5) 77 (6.0) 1.0
Blood loss
>5 L 6 (0.5%) 6 (9%) 91
1e2 L 281 (26%) 36 (57%) 11.7
2e5 L 33 (3%) 8 (13%) 22.2
Procedure
Open repair
of ruptured AAA
159 (15%) 47 (75%) 70.6
EVAR 54 (5%) 2 (3%) 8.8
Elective open
AAA repair
295 (27%) 11 (18%) 8.9
Haemoglobin (g/L) 13.4 (3.43) 11.3 (2.45) 0.6
White cell
count (109/L)
9.2 (3.86) 11.9 (5.41) 1.1
Elective admission 835 (77%) 15 (24%) 0.1
Abnormal ECG 485 (44%) 36 (57%) 2.7
Lowest intra-operative
systolic blood pressure
(mmHg)
126 (33.4) 106 (40.2) 0.9
Highest intra-operative
heart rate
(beats per minute)
78 (16.8) 93 (21.9) 1.0
ECG; electrocardiogram; AAA: abdominal aortic aneurysm; EVAR: endmodel, care by a vascular anaesthetist had no influence on
outcome (odds ratio 0.55; 95% CI 0.15e1.95) (Table 3).
Similarly, care by a vascular anaesthetist did not affect 30-
day outcome in patients undergoing emergency vascular
surgery (Tables 4e7).
Medium-term outcome
Median follow-up for the cohort was 583 days. There were
179 deaths during follow-up (16%). Mortality for the1155 patients).
ariate odds
o (95% CI)
P Multivariate odds
ratio (95% CI)
p
4 (0.09e0.59) 0.002 0.22 (0.12e0.62) 0.002
1 (1.00e1.02) <0.0001 1.01 (1.00e1.01) 0.02
9 (1.06e1.13) <0.0001 1.08 (1.03e1.14) 0.0008
.8 (21.87e385.2) <0.0001 18.12 (3.58e91.5) 0.005
6 (4.56e30.32) <0.0001 5.10 (1.83e14.27) 0.002
5 (6.89e71.84) <0.0001 4.17 (1.05e16.47) 0.04
5 (9.65e517.2) <0.0001 5.47 (2.62e11.46) <0.001
5 (0.79e99.40) 0.07 2.62(0.50e13.69) 0.25
1 (1.14e69.52) 0.04 0.75 (0.38e36.66) e
0.26
8 (0.61e0.76) <0.0001 0.92 (0.79e1.07) 0.28
0 (1.05e1.15) <0.0001 1.04 (0.96e1.13) 0.31
0 (0.05e0.17) <0.0001 127,387 (0.01e150,000) 0.98
6 (1.39e5.50) 0.003 1.66 (0.77e3.59) 0.19
8 (0.97e0.99) 0.0003 0.99 (0.98e1.01) 0.99
4 (1.03e1.05) <0.0001 1.01 (0.99e1.03) 0.46
ovascular aneurysm repair.
Table 3 Factors affecting 30-day mortality in elective patients (nZ 851).
Variable Alive at 30 days
(nZ 836)
Dead at 30 days
(nZ 15)
Univariate OR P Multivariate OR p
Vascular anaesthetist 262 (31%) 3 (20%) 0.55 (0.15e1.95) 0.35 e e
Age (years) 71.6 (8.49) 75.9 (5.12) 1.07 (0.99e1.15) 0.05 1.07 (0.98e1.16) 0.12
Operation time (min) 161 (54.5) 207 (108.2) 1.01 (1.00e1.02) 0.005 1.01 (1.00e1.02) 0.008
Procedure
Carotid endarterectomy 316 (38%) 1 (7%) 0.12 (0.12e0.90) 0.04 3.67 (0.71e18.95) 0.68
Elective open AAA repair 294 (35%) 11 (73%) 5.07 (1.60e16.06) 0.006 4.77 (1.28e14.77) 0.02
AAA: abdominal aortic aneurysm.
722 S.R. Walsh et al.subgroup cared for by vascular anaesthetists was 7% (20
deaths in 287 patients). For the overall cohort, care by
a vascular anaesthetist reduced the risk of death within
two years (Fig. 1) (hazard ratio 0.37; 95% CI 0.26e0.51;
P< 0.0001). The benefit persisted when the analysis was
restricted to elective patients only (hazard ratio 0.44; 95%
CI 0.28e0.69; PZ 0.004) (Fig. 2). The survival difference
did not reach statistical significance when the analysis was
restricted to emergency patients only (hazard ratio 0.48;
95% CI 0.25e0.93; PZ 0.09) (Fig. 3). Univariate logistic
regression again identified a number of significant correlates
with survival, including vascular anaesthesia (Table 5). In
a multivariate model, vascular anaesthesia was indepen-
dently associated with a reduction in mortality (multivar-
iate odds ratio 0.31; 95% CI 0.18e0.55). Although the
protection afforded by vascular anaesthesia appeared
independent of a diagnosis of rupture AAA in this model,
blood loss and pre-operative haemoglobin level were
associated with an increased mortality risk. To account for
potential confounding by the inclusion of ruptured aneu-
rysm and other emergency patients, we repeated theTable 4 Factors affecting 30-day mortality in emergency patie
Variable Alive at
30 days
(nZ 256)
Death within
30 days
(nZ 48)
U
Vascular anaesthetist 30 (12%) 2 (4%)
Creatininea 104 (88e131) 151 (112e182)
Age (years) 73 (8.7) 78 (6.3)
Blood loss
>5 L 6 (2%) 5 (10%)
1e2 L 93 (36%) 30 (63%)
Haemoglobin (g/dL) 12.6 (2.57) 10.7 (2.19)
Abnormal ECG 121 (47%) 27 (56%)
Lowest intra-operative
systolic blood pressure
(mmHg)
110 (37.4) 96 (38.3)
Highest heart
rate (beats per minute)
88 (19.8) 98 (22.9)
Procedure
Rupture AAA 159 (62%) 47 (98%) 2
Carotid 29 (11%) 1 (2%)
a Median (interquartile range); ECG: electrocardiogram; AAA; abdommodel using elective patients only (Table 6). In this model
(851 patients; 95 deaths) the only univariate correlates
with survival were vascular anaesthesia (odds ratio 0.29;
95% CI 0.15e0.58), age (odds ratio 1.09; 95% CI 1.05e1.13)
and intra-operative systolic blood pressure (odds ratio 1.01;
95% CI 0.99e1.02). In the multivariate model, only vascular
anaesthesia retained significance (multivariate odds ratio
0.44; 95% CI 0.23e0.79; PZ 0.004).
The models were repeated using datasets restricted to
emergency patients only, and excluding ruptured AAA
patients only (Table 7). Care by vascular anaesthetists did
not correlate with survival in these further models.
Discussion
Recent years have seen a rapid increase in surgical sub-
specialisation, driven by recognition of the relationship
between volume, specialisation and surgical outcome. In
vascular surgery, most procedures are now performed by
vascular surgeons and trainees, rather than by general
surgeons.11 In contrast, anaesthesia remains broad-based.nts (nZ 304).
nivariate OR P Multivariate OR p
0.33 (0.08e1.41) 0.13 e e
1.02 (1.01e1.02) <0.0001 1.01 (1.00e1.02) 0.0003
1.08 (1.03e1.14) 0.0003 1.11 (1.05e1.18) 0.0004
4.23 (1.25e14.83) 0.02 12.26 (2.47e60.65) 0.002
2.80 (1.35e5.77) 0.006 6.43 (2.29e18.05) 0.0004
0.75 (0.66e0.86) <0.0001 0.90 (0.77e1.06) 0.21
2.74 (1.14e6.58) 0.02 1.73 (0.62e4.81) 0.29
0.99 (0.98e1.00) 0.05 0.99 (0.98e1.01) 0.73
1.02 (1.01e1.04) 0.008 1.01 (0.99e1.04) 0.25
8.67 (3.89e211.17) 0.001 1,735,307 (0.01 to N) 0.98
0.17 (0.02e1.25) 0.08 0.96 (0.01e2.00) 0.99
inal aortic aneurysm.
Table 5 Logistic regression analyses of factors affecting medium-term survival in the entire cohort (1155 patients).
Variable Alive at
2 years
(nZ 976)
Death within
2 years
(nZ 179)
Univariate OR P Multivariate OR p
Vascular anaesthetist 280 (29%) 20 (11%) 0.30 (0.19e0.49) <0.0001 0.31 (0.18e0.55) <0.0001
Age (years) 71 (8.5) 76 (6.6) 1.11 (1.08e1.14) <0.0001 1.10 (1.06e1.12) <0.0001
Haemoglobin (g/dL) 13.5 (3.54) 12.1 (2.33) 0.74 (0.69e0.80) <0.0001 0.86 (0.79e0.94) 0.001
White cell count (x109/L) 9.2 (3.91) 10.8 (4.76) 1.08 (1.05e1.12) <0.0001 1.06 (1.02e1.10) 0.004
Creatinine (mmol/L)a 99 (84e119) 117 (93e151) 1.01 (1.00e1.01) <0.0001 1.01 (1.00e1.02) 0.01
Urea (mg/L)a 6.3 (5.1e8.0) 7.8 (5.7e10.1) 1.01 (0.99e1.02) 0.07 0.96 (0.88e1.04) 0.32
Sodium (mmol/L) 139 (12.7) 137 (14.8) 0.99 (0.97e0.99) 0.02 0.99 (0.96e1.02) 0.39
Elective admission 756 (78%) 96 (54%) 0.31 (0.23e0.43) <0.0001 0.96 (0.53e1.76) 0.91
Ischaemic heart
disease/congestive cardiac
failure
361 (37%) 74 (41%) 1.40 (0.98e1.98) 0.06 1.23 (0.78e1.93) 0.38
Abnormal ECG 437 (45%) 84 (47%) 1.49 (1.02e2.19) 0.04 0.83 (0.47e1.47) 0.53
Highest heart
rate (beats per minute)
78 (16.5) 86 (21.6) 1.02 (1.01e1.04) <0.0001 1.01 (0.99e1.02) 0.29
Blood loss
>5 L 8 (1%) 4 (2%) 16.94 (4.92e58.31) <0.0001 3.45 (0.89e13.33) 0.07
1e2 L 253 (26%) 64 (36%) 2.14 (1.43e3.21) 0.0002 1.49 (0.96e2.31) 0.07
2e5 L 25 (3%) 16 (9%) 5.42 (2.71e10.85) <0.0001 2.01 (0.91e4.47) 0.08
Procedure
Open repair
of ruptured AAA
136 (14%) 70 (39%) 2.92 (1.85e4.61) <0.0001 0.82 (0.28e2.56) 0.76
Carotid endarterectomy 315 (32%) 32 (18%) 0.58 (0.35e0.96) 0.03 1.12 (0.53e1.29) 0.76
a Median (interquartile range) ECG: electrocardiogram; AAA: abdominal aortic aneurysm.
Anaesthetic Specialisation and Outcome 723Apart from intensive care, paediatric and cardiac anaes-
thesia, the majority of anaesthetists remain generalists,
taking care of patients undergoing a variety of surgical
procedures. The present data suggest that a degree of
anaesthetic specialisation is associated with reductions in
both peri-operative and medium-term mortality.
In models using the entire cohort of 1155 patients,
vascular anaesthesia significantly reduced both 30-day and
medium-term mortality. When the analysis was restricted
to elective patients only, vascular anaesthesia retained
benefit with respect to medium-term outcome. There was
no effect on 30-day outcome. However, with only 15 peri-
operative deaths in the elective group, the analysis is likelyTable 6 Factors affecting medium-term survival in elective pat
Variable Alive at
2 years (nZ 756)
Death within
2 years (nZ 95)
Vascular anaesthetist 251 (33%) 14 (15%)
Age (years) 71 (8.5) 76 (6.3)
Haemoglobin (g/dL) 13.7 (3.75) 12.9 (1.93)
Creatinine (mmol/L) 106 (41.5) 124 (67.2)
Lowest intra-operative
systolic blood pressure
(mmHg)
129 (30.8) 140 (27.6)
Procedure
Carotid endartectomy 289 (38%) 28 (29%)to be underpowered. Our results should not be interpreted
as ruling out benefit in this subgroup. Similarly, the rela-
tively small size of the emergency subgroup (304 patients)
means that benefit cannot be ruled out in these patients.
The survival curves for emergency patients are diverging at
two years (Fig. 3) and the 95% confidence interval for the
hazard ratio does not cross one. Further follow-up or
further patients may yield a significant difference.
Why should vascular anaesthetic specialisation improve
medium-term outcome, long after the peri-operative
period? Asymptomatic peri-operative cardiac injury is
associated with increased mortality for several years after
major vascular surgery.12,13 Peri-operative haemodynamicients (nZ 851).
Univariate OR P Multivariate OR p
0.35 (0.19e0.62) 0.0004 0.29 (0.15e0.58) 0.0004
1.09 (1.05e1.13) <0.0001 1.09 (1.05e1.13) <0.0001
0.81 (0.72e0.91) 0.0004 0.96 (0.81e1.13) 0.63
1.01 (1.00e1.01) 0.001 1.00 (0.99e1.01) 0.36
1.01 (1.00e1.02) 0.008 1.01 (0.99e1.02) 0.10
0.55 (0.31e0.97) 0.04 0.98 (0.58e1.69) 0.96
Table 7 Factors affecting medium-term survival in emergency patients (nZ 304).
Variable Alive at 2 years
(nZ 220)
Death within
2 years (nZ 84)
Univariate OR P Multivariate OR p
Vascular anaesthetist 27 5 0.45 (0.17e1.21) 0.11 e e
Age (years) 72 (8.5) 79 (6.7) 1.12 (1.07e1.16) <0.0001 1.15 (1.09e1.22) <0.0001
Creatinine (mmol/L)a 103 (88e124) 132 (96e167) 1.01 (1.00e1.02) <0.0001 1.01 (1.00e1.02) 0.01
Blood loss
>5 L 4 (2%) 7 (8%) 15.30 (3.67e63.97) 0.0002 8.38 (1.65e42.66) 0.01
1e2 L 84 (38%) 39 (46%) 4.06 (1.78e9.26) 0.0009 3.90 (1.50e10.12) 0.005
2e5 L 13 (6%) 14 (17%) 9.42 (3.29e26.96) <0.0001 6.41 (1.80e22.81) 0.004
Sodium (mmol/L) 139 (3.4) 136 (15.6) 0.91 (0.85e0.97) 0.004 0.90 (0.82e1.00) 0.05
Haemoglobin (g/dL) 12.7 (2.55) 11.2 (2.43) 0.79 (0.71e0.88) <0.0001 0.94 (0.81e1.09) 0.43
Ischaemic heart
disease/congestive
cardiac failure
75 39 1.81 (1.05e3.13) 0.03 1.62 (0.80e3.27) 0.18
Highest heart
rate (beats per
minute)
87 (19.6) 98 (22.2) 1.02 (1.01e1.04) 0.004 0.99 (0.98e1.02) 0.77
Procedure
Open repair
of ruptured AAA
136 (62%) 70 (83%) 3.60 (1.21e10.68) 0.02 0.54 (0.09e2.97) 0.48
AAA: abdominal aortic aneurysm.
724 S.R. Walsh et al.stability may reduce the risk of peri-operative myocardial
injury so one can speculate that greater haemodynamic
stability whilst under the care of a vascular anaesthetist
may reduce myocardial stress and subsequently asymp-
tomatic damage, thereby improving medium-term prog-
nosis. The database contained the maximum recorded
intra-operative heart rate and minimum recorded systolic
blood pressure for each patient. Surprisingly, elective
patients cared for by a vascular anaesthetist tended to
have a lower mean systolic blood pressure (120 versus
135 mmHg; P< 0.0001) and a higher maximum heart rate
(77 versus 73 beats per minute; PZ 0.0002). However,
elective vascular anaesthesia patients had a lower range of
systolic blood pressures (145 versus 290 mmHg) althoughFigure 1 Survival curves for 1155 patients receiving care
from a general anaesthetist (B; Group 0) or a vascular
anaesthetist (,; Group 1). Numbers at risk (standard error of
survival hazard) are displayed along the horizontal axis.the ranges for heart rate were similar (88 versus 90 beats
per minute). The lower blood pressure range in the vascular
anaesthesia patients may reflect tighter blood pressure
control, despite the lower mean systolic.
Could the apparent benefit from vascular anaesthesia
simply be a surrogate marker of simple differences in other
aspects of care? The database does not contain pre-
operative medications, which may have confounded the
results. Peri-operative beta-blockade is not routinely used
in Norwich. Patients established on beta-blockers continue
them peri-operatively, but not routinely commenced pre-
operatively. Statins are routinely started in all major
vascular patients peri-operatively, if they are not already
taking them. Epidural anaesthesia may improve outcome,Figure 2 Survival curves for 851 elective patients receiving
care from a general anaesthetist (B; Group 0) or a vascular
anaesthetist (,; Group 1). Numbers at risk (standard error of
survival hazard) are displayed along the horizontal axis.
Figure 3 Survival curves for 304 emergency patients
receiving care from a general anaesthetist (B; Group 0) or
a vascular anaesthetist (,; Group 1). Numbers at risk (stan-
dard error of survival hazard) are displayed along the hori-
zontal axis.
Anaesthetic Specialisation and Outcome 725but there was no difference in the frequency of use of
epidural anaesthesia between vascular and non-vascular
anaesthetists (47% versus 42%; PZ 0.16).
If repeated in other series, our findings have implications
for service provision, suggesting that all elective major
vascular surgery patients should be cared for anaesthetists
with a special interest. If larger datasets identify a similar
pattern in emergency vascular surgery, then separate
vascular anaesthetic on-call rotas would be required. In the
meantime, it should be noted that vascular surgical emer-
gencies often require prompt surgical intervention to save
life or limb. In such circumstances, intervention should not
be delayed whilst seeking specialist anaesthetic support.
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